![Abdelmalik Slassi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Abdelmalik Slassi
Direktor/Vorstandsmitglied bei
Pharmala Biotech, Inc.
Vermögen: 79 500 $ am 30.09.2026
Profil
Abdelmalik Slassi was the founder of Mindset Pharma, Inc., founded in 2019, holding the title of Senior Vice President-Innovation.
Dr. Slassi is also the founder of Fluorinov Pharma, Inc...
Dr. Slassi is currently Director at Pharmala Biotech, Inc. Former positions include Director & Vice President-Medicinal Chemistry at NPS Pharmaceuticals, Inc., Independent Director at Pharmala Biotech Holdings, Inc. from 2021 to 2026, Director & VP-Manufacturing & Drug Development at Cascade Therapeutics, Inc., and Senior Vice President-Drug Discovery Research at Trillium Therapeutics, Inc. from 2016 to 2019.
Education includes a doctorate from Université Claude Bernard Lyon 1.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2025 | 500’000 ( 0.46% ) | 79 500 $ | 30.09.2026 |
Aktive Positionen von Abdelmalik Slassi
| Unternehmen | Position | Beginn |
|---|---|---|
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Abdelmalik Slassi
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Direktor/Vorstandsmitglied | 09.02.2026 |
| TRILLIUM THERAPEUTICS | Corporate Officer/Principal | 01.12.2019 |
Fluorinov Pharma, Inc.
 Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Gründer | 01.01.2016 |
| MINDSET PHARMA INC. | Gründer | - |
Cascade Therapeutics, Inc.
 Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Direktor/Vorstandsmitglied | - |
Ausbildung von Abdelmalik Slassi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fluorinov Pharma, Inc.
Fluorinov Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Cascade Therapeutics, Inc.
Cascade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research of biological products | Commercial Services |
Mindset Pharma, Inc.
 Mindset Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for psychiatric and neurological disorders | Health Technology |
PharmAla Biotech Holdings, Inc.
 PharmAla Biotech Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops and sells pharmaceutical ingredients | Health Technology |
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which manufactures and sells MDMA and MDXX class molecules | Health Technology |
